Soligenix adds shares, wins reverse split approval
Soligenix shareholders approved more authorized shares, reverse-split authority, and a larger at-the-market equity program.
Rhea-AI Filing Summary
Soligenix, Inc. (SNGX) reported results of its September 17, 2026 annual meeting, where stockholders approved an amendment to its Certificate of Incorporation increasing authorized common stock from 75,000,000 to 125,000,000, effective upon filing with the Delaware Secretary of State on September 17, 2026.
Stockholders also approved a charter amendment authorizing the board, for up to one year, to implement a reverse stock split of issued and outstanding common stock at a ratio between 1-for-2 and 1-for-20, with the exact ratio to be set and publicly announced by the board. All five director nominees were elected, say-on-pay and an annual frequency for future say-on-pay votes were approved, the appointment of Cherry Bekaert LLP as auditor for 2026 was ratified, and an adjournment proposal was approved.
Separately, Soligenix disclosed that on June 26, 2026 it filed a prospectus supplement increasing by $2,500,000 the maximum aggregate amount of common stock issuable under its At Market Issuance Sales Agreement with Rodman & Renshaw LLC. The company has previously sold approximately $6,234,000 of common stock under prior supplements covering up to $6,406,000.
Positive
- None.
Negative
- None.
Insights
Analyzing...
8-K Event Classification
4 items: 5.03, 5.07, 8.01, 9.01
4 items
Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Authorized common shares before amendment: 75,000,000 shares
Authorized common shares after amendment: 125,000,000 shares
Reverse stock split ratio range: 1-for-2 to 1-for-20
+5 more
8 metrics
Authorized common shares before amendment
75,000,000 shares
Authorized common stock prior to Charter Amendment approved September 17, 2026
Authorized common shares after amendment
125,000,000 shares
Authorized common stock after Charter Amendment became effective September 17, 2026
Reverse stock split ratio range
1-for-2 to 1-for-20
Range of reverse split ratios authorized at board discretion for up to one year
Additional ATM capacity
$2,500,000
Increase in maximum aggregate offering amount under At Market Issuance Sales Agreement per June 26, 2026 prospectus supplement
Common stock sold under ATM to date
$6,234,000
Approximate amount of common stock previously sold under the Sales Agreement
Prior ATM coverage
$6,406,000
Aggregate amount of common stock covered by prior prospectus supplements under the Sales Agreement
Votes for authorized share increase
8,214,549 votes
For votes on proposal to increase authorized common shares to 125,000,000
Votes for reverse split authority
8,068,017 votes
For votes on proposal authorizing reverse stock split at 1-for-2 to 1-for-20
Key Terms
reverse stock split, broker non-votes, At Market Issuance Sales Agreement, prospectus supplement, +2 more
6 terms
reverse stock split financial
"effect a reverse stock split with respect to the issued and outstanding Common Stock"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
broker non-votes regulatory
"There were 7,470,895 broker non-votes in the election of directors."
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
At Market Issuance Sales Agreement financial
"issuable under the At Market Issuance Sales Agreement, dated January 23, 2026"
An at market issuance sales agreement is a setup where a company arranges for an agent to sell newly issued shares directly into the public market at the current trading price, usually over time as needed. It matters to investors because it gives the company quick, flexible access to cash without setting a fixed price, but can dilute existing shareholders and affect the stock’s supply and short‑term price behavior—like a shop owner adding extra items to a shelf and selling them at whatever the going price is.
prospectus supplement regulatory
"filed a prospectus supplement (the “Current Prospectus Supplement”) to increase"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
non-binding advisory vote regulatory
"The proposal to approve, by a non-binding advisory vote, the compensation"
A non-binding advisory vote is a shareholder vote that expresses investors’ opinion on a proposal (such as executive pay, corporate policy, or governance practices) but does not legally force the company to act. Think of it like a customer survey: it signals whether owners approve or disapprove and can pressure boards and managers to change course, so investors watch the result as an indicator of governance risk and potential future shifts in company strategy or leadership.
adjournment of the Annual Meeting regulatory
"The proposal to approve an adjournment of the Annual Meeting, in whole or in part"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What reverse stock split authority did Soligenix (SNGX) obtain?
Stockholders approved an amendment allowing the board, for up to one year, to effect a reverse stock split of issued and outstanding common stock at a ratio between 1-for-2 and 1-for-20, with the specific ratio to be chosen and publicly announced by the board.
How much additional ATM capacity did Soligenix (SNGX) register?
On June 26, 2026, Soligenix filed a prospectus supplement to increase by an additional $2,500,000 the maximum aggregate offering amount of common stock issuable under its At Market Issuance Sales Agreement with Rodman & Renshaw LLC.
How much has Soligenix (SNGX) already sold under its ATM program?
Soligenix disclosed that it has previously sold approximately $6,234,000 of common stock under the At Market Issuance Sales Agreement, pursuant to prior prospectus supplements that covered an aggregate of up to $6,406,000 of common stock.
Which directors were elected at the Soligenix (SNGX) 2026 annual meeting?
Five nominees were elected to serve until the 2027 annual meeting: Christopher J. Schaber, PhD; Gregg A. Lapointe, CPA, MBA; Diane L. Parks, MBA; Robert J. Rubin, MD; and Jerome B. Zeldis, MD, PhD.
Did Soligenix (SNGX) stockholders approve executive compensation in 2026?
Yes. A non-binding advisory vote to approve the compensation of the company’s named executive officers was approved with 2,658,319 votes for, 416,320 against, and 65,111 abstentions, with 7,470,895 broker non-votes.
What auditor did Soligenix (SNGX) stockholders ratify for 2026?
Stockholders ratified the appointment of Cherry Bekaert LLP as Soligenix’s independent registered public accounting firm for the year ending December 31, 2026, with 9,833,435 votes for, 414,426 against, and 362,784 abstentions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
